Application of dna chip scanning technology for automatic detection of chlamydia trachomatis and chlamydia pneumoniae inclusions

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 1, 2014, Pages 405-413

  Bogdanov, Anita ^a   Endrész, Valeria ^a   Urbán, Szabolcs ^a   Lantos, Ildikó ^a   Deák, Judit ^a   Burián, Katalin ^a   Önder, Kamil ^b   Ayaydin, Ferhan ^c   Balázs, Péter ^a   Virok, Dezsö P ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOHEXIMIDE; DIETHYLAMINOETHYLDEXTRAN; DOXYCYCLINE; GAMMA INTERFERON; MOXIFLOXACIN; PCC 00213; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIUM DETECTION; CELL COUNTER; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPE; DNA MICROARRAY; FEMALE; FIBROBLAST; FLUORESCENCE MICROSCOPY; HELA CELL; HOST CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGING SOFTWARE; IMMUNOFLUORESCENCE TEST; MINIMUM BACTERICIDAL CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; INCLUSION BODIES; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84891513311     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01400-13     Document Type: Article

References (26)

1. Sutherland ER, Martin RJ. 2007. Asthma and atypical bacterial infection. Chest 132:1962-1966. http://dx.doi.org/10.1378/chest.06-2415.
2. Rosenfeld ME, Campbell LA. 2011. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to thepathogenesis of atherosclerosis. Thromb. Haemost. 106:858-867. http://dx.doi.org/10.1160/ TH11-06-0392.
3. Wagenlehner FM, Wullt B, Perletti G. 2011. Antimicrobials in urogenital infections. Int. J. Antimicrob. Agents 38(Suppl):3-10. http://dx.doi.org/10. 1016/j.ijantimicag.2011.09.004.
4. Campbell JP, Mkocha H, Munoz B, West SK. 2012. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania. Ophthalmic Epidemiol. 19:38-42. http://dx.doi.org/10.3109/09286586.2011.627490.
5. Mishori R, McClaskey EL, WinklerPrins VJ. 2012. Chlamydia trachomatis infections: Screening, diagnosis, and management. Am. Fam. Physician 86:1127-1132.
6. O'Neill CE, Seth-Smith HM, Van Der Pol B, Harris SR, Thomson NR, Cutcliffe LT, Clarke IN. 2013. Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: Wholegenome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes. Microbiology 159(Pt 4):748-756. http://dx.doi.org/10.1099/mic.0.065391-0.
7. Bhengraj AR, Srivastava P, Mittal A. 2011. Lack of mutation in macrolide resistance genes in Chlamydia trachomatis clinical isolates with decreased susceptibility to azithromycin. Int. J. Antimicrob. Agents 38:178- 179. http://dx.doi.org/10.1016/j.ijantimicag.2011.03.015.
8. Collins TJ. 2007. ImageJ for microscopy. Biotechniques 43:25-30. http://dx.doi.org/10.2144/000112505.
9. Sabet SF, Simmons J, Caldwell HD. 1984. Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J. Clin. Microbiol. 20:217-222.
10. Rodel J, Woytas M, Groh A, Schmidt KH, Hartmann M, Lehmann M, Straube E. 2000. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect. Immun. 68:3635-3641. http://dx.doi.org/10.1128/IAI.68.6.3635-3641.2000.
11. Burian K, Hegyesi H, Buzas E, Endresz V, Kis Z, Falus A, Gonczol E. 2003. Chlamydophila (Chlamydia) pneumoniae induces histidine decarboxylase production in the mouse lung. Immunol. Lett. 89:229-236. http://dx.doi.org/10.1016/S0165- 2478(03)00154-8.
12. Osaka I, Hills JM, Kieweg SL, Shinogle HE, Moore DS, Hefty PS. 2012. An automated image-based method for rapid analysis of Chlamydia infection as a tool for screening antichlamydial agents. Antimicrob. Agents Chemother. 56:4184-4188. http://dx.doi.org/10.1128/AAC.00427-12.
13. Lundholt BK, Scudder KM, Pagliaro L. 2003. A simple technique for reducing edge effect in cell-based assays. J. Biomol. Screen. 8:566-570. http://dx.doi.org/10.1177/1087057103256465.
14. Peuchant O, Duvert JP, Clerc M, Raherison S, Bebear C, Bebear CM, de Barbeyrac B. 2011. Effects of antibiotics on Chlamydia trachomatis viability as determined by real-time quantitative PCR. J. Med. Microbiol. 60:508-514. http://dx.doi.org/10.1099/jmm.0.023887-0.
15. Donati M, Rodriguez Fermepin M, Olmo A, D'Apote L, Cevenini R. 1999. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. J. Antimicrob. Chemother. 43:825- 827. http://dx.doi.org/10.1093/jac/43.6.825.
16. Shima K, Szaszak M, Solbach W, Gieffers J, Rupp J. 2011. Impact of a low-oxygen environment on the efficacy of antimicrobials against intracellular Chlamydia trachomatis. Antimicrob. Agents Chemother. 55: 2319-2324. http://dx.doi.org/10.1128/AAC.01655-10.
17. Ikeda-Dantsuji Y, Feril LB, Jr, Tachibana K, Ogawa K, Endo H, Harada Y, Suzuki R, Maruyama K. 2011. Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro. Ultrason. Sonochem. 18:425-430. http://dx.doi.org/10.1016/j.ultsonch.2010.07. 015.
18. Welsh LE, Gaydos CA, Quinn TC. 1992. In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. Antimicrob. Agents Chemother. 36:291-294. http://dx.doi.org/10.1128/AAC.36.2.291.
19. Byrne GI, Lehmann LK, Landry GJ. 1986. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:347-351.
20. Thomas BJ, Evans RT, Hutchinson GR, Taylor-Robinson D. 1977. Early detection of chlamydial inclusions combining the use of cycloheximidetreated McCoy cells and immunofluorescence staining. J. Clin. Microbiol. 6:285-292.
21. Evans RT, Taylor-Robinson D. 1979. Comparison of various McCoy cell treatment procedures used for detection of Chlamydia trachomatis. J. Clin. Microbiol. 10:198-201.
22. Benes S, McCormack WM. 1982. Comparison of methods for cultivation and isolation of Chlamydia trachomatis. J. Clin. Microbiol. 16:847-850.
23. Wang S, Indrawati L, Wooters M, Caro-Aguilar I, Field J, Kaufhold R, Payne A, Caulfield MJ, Smith JG, Heinrichs JH. 2007. A novel automated method for enumeration of Chlamydia trachomatis inclusion forming units. J. Immunol. Methods 324:84-91. http://dx.doi.org/10.1016/j.jim.2007.05.004.
24. Beeckman DS, Meesen G, Van Oostveldt P, Vanrompay D. 2009. Digital titration: Automated image acquisition and analysis of load and growth of Chlamydophila psittaci. Microsc. Res. Tech. 72:398-402. http://dx.doi.org/10. 1002/jemt.20694.
25. Osaka I, Hefty PS. 2013. Simple resazurin-based microplate assay for measuring Chlamydia infections. Antimicrob. Agents Chemother. 57: 2838-2840. http://dx.doi.org/10.1128/AAC.00056-13.
26. Southern T, Bess L, Harmon J, Taylor L, Caldwell H. 2012. Fluorometric high-throughput assay for measuring chlamydial neutralizing antibody. Clin. Vaccine Immunol. 19:1864-1869. http://dx.doi.org/10.1128 /CVI.00460-12.